433 related articles for article (PubMed ID: 29660202)
21. Genomic landscape of endometrial stromal sarcoma of uterus.
Choi YJ; Jung SH; Kim MS; Baek IP; Rhee JK; Lee SH; Hur SY; Kim TM; Chung YJ; Lee SH
Oncotarget; 2015 Oct; 6(32):33319-28. PubMed ID: 26429873
[TBL] [Abstract][Full Text] [Related]
22. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.
Hoang LN; Aneja A; Conlon N; Delair DF; Middha S; Benayed R; Hensley ML; Park KJ; Hollmann TJ; Hameed MR; Antonescu CR; Soslow RA; Chiang S
Am J Surg Pathol; 2017 Jan; 41(1):12-24. PubMed ID: 27631520
[TBL] [Abstract][Full Text] [Related]
23. Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22.
Holzmann C; Koczan D; Loening T; Rommel B; Bullerdiek J
Anticancer Res; 2017 May; 37(5):2233-2237. PubMed ID: 28476787
[TBL] [Abstract][Full Text] [Related]
24. Utility of
Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
[TBL] [Abstract][Full Text] [Related]
25. Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC; Bennett JA
Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
[TBL] [Abstract][Full Text] [Related]
26. HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract.
Williams EA; Montesion M; Lincoln V; Tse JY; Hiemenz MC; Mata DA; Shah BB; Shoroye A; Alexander BM; Werth AJ; Foley-Peres K; Milante RR; Ross JS; Ramkissoon SH; Williams KJ; Adhikari LJ; Zuna RE; LeBoit PE; Lin DI; Elvin JA
Am J Surg Pathol; 2022 Jun; 46(6):729-741. PubMed ID: 35034043
[TBL] [Abstract][Full Text] [Related]
27. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
[TBL] [Abstract][Full Text] [Related]
28. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
[TBL] [Abstract][Full Text] [Related]
29. Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
Mäkinen N; Aavikko M; Heikkinen T; Taipale M; Taipale J; Koivisto-Korander R; Bützow R; Vahteristo P
PLoS Genet; 2016 Feb; 12(2):e1005850. PubMed ID: 26891131
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.
Huang HY; Ladanyi M; Soslow RA
Am J Surg Pathol; 2004 Feb; 28(2):224-32. PubMed ID: 15043312
[TBL] [Abstract][Full Text] [Related]
33. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
[TBL] [Abstract][Full Text] [Related]
34. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas.
Hrzenjak A
Orphanet J Rare Dis; 2016 Feb; 11():15. PubMed ID: 26879382
[TBL] [Abstract][Full Text] [Related]
35. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
36. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.
Hrzenjak A; Moinfar F; Tavassoli FA; Strohmeier B; Kremser ML; Zatloukal K; Denk H
J Mol Diagn; 2005 Aug; 7(3):388-95. PubMed ID: 16049311
[TBL] [Abstract][Full Text] [Related]
37. JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report.
Fujiishi K; Nagata S; Kano R; Kubo C; Shirayanagi M; Ozaki M; Yamamoto T; Nakanishi K; Kamiura S; Nakatsuka SI
Diagn Pathol; 2019 Oct; 14(1):110. PubMed ID: 31615558
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
[TBL] [Abstract][Full Text] [Related]
39. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
40. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
